Market Tracker

09/18 3:45pm ET

Nektar Therapeutics (NASDAQ:NKTR)

13.35
Real-Time Quote
 -0.37 / -2.70%
Today’s Change
8.87
Today|||52-Week Range
15.34
+17.62%
Year-to-Date

Today’s Trading

Previous close13.72
Today’s open13.73
Day’s range13.25 - 13.76
Volume1,275,486
Average volume (3 months)1,149,058
Market cap$1.7B
Dividend yield--
Data as of 3:30pm ET, 09/18/2014

Growth & Valuation

Earnings growth (last year)+6.67%
Earnings growth (this year)+53.84%
Earnings growth (next 5 years)+35.25%
Revenue growth (last year)+83.42%
P/E ratioNM
Price/Sales8.82
Price/Book--

Competitors

 Today’s
change
Today’s
% change
ABCOAdvisory Board Co-0.03-0.06%
DYAXDyax Corp-0.06-0.57%
KERXKeryx Biopharmaceuti...-0.00-0.04%
ARIAARIAD Pharmaceutical...-0.21-3.47%
Data as of 3:45pm ET, 09/18/2014

Financials

Next reporting dateNovember 5, 2014
EPS forecast (this quarter)$0.39
Annual revenue (last year)$148.9M
Annual profit (last year)-$162.0M
Net profit margin-108.79%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Financial Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts